Moderna Inc reported $375M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 104.4M 26.29M
Acorda Therapeutics ACOR:US USD 26.25M 3.26M
Agios Pharmaceuticals AGIO:US USD 32.77M 3.65M
Alnylam Pharmaceuticals ALNY:US USD 210.34M 25.52M
Amgen AMGN:US USD 1.47B 181M
Arrowhead Research ARWR:US USD 22.65M 8.97M
Biogen BIIB:US USD 632.8M 69.5M
Biomarin Pharmaceutical BMRN:US USD 245.74M 28.92M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Esperion Therapeutics ESPR:US USD 24.14M 816K
Gilead Sciences GILD:US USD 2.02B 807M
GlaxoSmithKline GSK:LN GBP 2.44B 467M
Intercept Pharmaceuticals ICPT:US USD 55.29M 12.02M
Mirati Therapeutics MRTX:US USD 70.82M 10.02M
Puma Biotechnology PBYI:US USD 25.04M 1.08M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Sangamo Biosciences SGMO:US USD 16.44M 205K
Sarepta Therapeutics SRPT:US USD 120.48M 15.69M
Seattle Genetics SGEN:US USD 216.1M 5.72M
Ultragenyx Pharmaceutical RARE:US USD 72.85M 3.01M
United Therapeutics UTHR:US USD 152M 53.6M
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
YTE INCY:US USD 272.82M 6.36M